- Home
- Publications
- Publication Search
- Publication Details
Title
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 6, Issue 4, Pages 355-362
Publisher
Informa UK Limited
Online
2013-07-31
DOI
10.1586/17512433.2013.811826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
- (2013) Bob W. van Oosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient Treated with Fumaric Acid
- (2013) Ummehan Ermis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
- (2012) Anke Stroet et al. Therapeutic Advances in Neurological Disorders
- The Anti-Inflammatory Effects of Dimethyl Fumarate in Astrocytes Involve Glutathione and Haem Oxygenase-1
- (2011) Shao Xia Lin et al. ASN Neuro
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
- (2011) R. Gold et al. CLINICAL IMMUNOLOGY
- Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
- (2011) Douglas S Goodin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
- (2010) Henrik Wilms et al. Journal of Neuroinflammation
- BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis
- (2010) D. G. MacManus et al. JOURNAL OF NEUROLOGY
- Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
- (2010) David B Clifford et al. LANCET NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Fumaric Acids on Cuprizone Induced Central Nervous System De- and Remyelination in the Mouse
- (2010) Darius Moharregh-Khiabani et al. PLoS One
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started